← Back to events
ActiveBusiness

FDA Launches Expedited IND Pilot, Begins Accepting Applications

What happened

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.

Summary assembled by rule from the sources below

Why it's spreading

Sources